Endava (DAVA)
(Delayed Data from NYSE)
$23.71 USD
+0.06 (0.25%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $23.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$23.71 USD
+0.06 (0.25%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $23.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Zacks News
Teradyne (TER) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Teradyne's (TER) fourth-quarter 2022 results are likely to reflect strength in System Test, Universal Robots and MiR amid weak test and industrial demand.
What's in the Cards for STMicroelectronics' (STM) Q4 Earnings?
by Zacks Equity Research
STMicroelectronics' (STM) fourth-quarter results are likely to reflect benefits from end-market momentum. However, supply-chain disruptions are likely to have been concerning.
What's in the Offing for ASML Holding's (ASML) Q4 Earnings?
by Zacks Equity Research
ASML Holding's (ASML) fourth-quarter results are expected to reflect the benefits of strong momentum across EUV systems, DUV systems and logic.
What's in the Store for TE Connectivity's (TEL) Q1 Earnings?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal first-quarter results are expected to reflect solid momentum across the industrial, communication and transportation segments amid supply constraints.
What's in the Offing for Texas Instruments' (TXN) Q4 Earnings?
by Zacks Equity Research
Texas Instruments' (TXN) fourth-quarter 2022 results are expected to reflect solid momentum across Analog and Embedded processing segments amid supply-chain woes.
Lam Research (LRCX) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Lam Research's (LRCX) second-quarter fiscal 2023 results are likely to gain from strong demand for semiconductor equipment. However, supply-chain constraints might have been a headwind.
Will Endava PLC Sponsored ADR (DAVA) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in Store for Taiwan Semiconductor's (TSM) Q4 Earnings?
by Zacks Equity Research
Taiwan Semiconductor's (TSM) fourth-quarter 2022 results are expected to reflect gains from the robust technology portfolio amid geopolitical tensions.
Endava PLC Sponsored ADR (DAVA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) closed the most recent trading day at $71.81, moving +0.91% from the previous trading session.
Endava PLC Sponsored ADR (DAVA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) closed the most recent trading day at $76.50, moving -0.65% from the previous trading session.
Endava PLC Sponsored ADR (DAVA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) closed the most recent trading day at $74.78, moving -1.11% from the previous trading session.
Zacks.com featured highlights include Clovis Oncology, NiSource, DocuSign, Root and Endava
by Zacks Equity Research
Clovis Oncology, NiSource, DocuSign, Root and Endava are part of the Zacks Screen of the Week article.
Bet on 5 Top Stocks With Rising P/E
by Sanghamitra Saha
Forget undervalued stocks, play top-ranked stocks like Clovis Oncology (CLVS), NiSource (NI), DocuSign (DOCU), Root (ROOT) and Endava (DAVA).
Will Endava PLC Sponsored ADR (DAVA) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Endava PLC Sponsored ADR (DAVA) Have the Potential to Rally 27% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 27.2% upside potential for Endava PLC Sponsored ADR (DAVA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Endava PLC Sponsored ADR (DAVA) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Endava PLC Sponsored ADR (DAVA) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
New Strong Buy Stocks for November 29th
by Zacks Equity Research
CBRL, UOVEY, BRDCY, AIT and DAVA have been added to the Zacks Rank #1 (Strong Buy) List on November 29, 2022.
Endava PLC Sponsored ADR (DAVA) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Company News for Nov 16, 2022
by Zacks Equity Research
Companies in The News Are: TGT, TSM, BRK.B, NOC, DAVA
Endava PLC Sponsored ADR (DAVA) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) delivered earnings and revenue surprises of 16.36% and 12.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Grid Dynamics (GDYN) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Grid Dynamics (GDYN) delivered earnings and revenue surprises of 25% and 2.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Endava's (DAVA) Q4 Earnings Rise Y/Y on Strong Top-Line Growth
by Zacks Equity Research
Endava's (DAVA) fourth-quarter fiscal 2022 results benefit from expanding clientele and robust performance by the Payments and Financial Services vertical.
Endava PLC Sponsored ADR (DAVA) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) delivered earnings and revenue surprises of 6.67% and 3.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Endava PLC Sponsored ADR (DAVA) to Report Q4 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.